GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 dos
7680578500015
CH-57850
V01AA02
07.13.3.
Reimbursement limitations:
071330
Prise en charge seulement après exploration allergologique.
1 / 3
google
Details
- Product number
- 5785001
- CPT
- -
- Packaging group
- 30
- Unit
- Einzeldose(n)
- Composition
- pollinis allergeni extractum (Phleum pratense) (phleum pratense) 75000 U., gelatina, mannitolum 12.7 mg, natrii hydroxidum corresp. natrium 0.54 mg, pro dosi.
Articles (1)
Grazax, Lyophilisat zum Einnehmen
Lyophilisat
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
75000.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
12.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.54 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 110.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2009
Authorization holder
ALK-Abelló AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 57850
- Drug name
- Grazax, Lyophilisat zur sublingualen Anwendung
- Galenic form
- LYSUV
- ATC Code
- V01AA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/06/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.13.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 dos
- Description (DE)
- GRAZAX Lyophilisat oral 75000 SQ-T 30 x 1 Dos
- Market launch
- 29/06/2007
- Narcotic (BTM)
- No